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Abstract
The genetic dissection of the phenotypes associated with Williams-Beuren Syndrome (WBS) is advancing thanks to the
study of individuals carrying typical or atypical structural rearrangements, as well as in vitro and animal studies. However,
little is known about the global dysregulations caused by the WBS deletion. We profiled the transcriptomes of skin
fibroblasts from WBS patients and compared them to matched controls. We identified 868 differentially expressed genes
that were significantly enriched in extracellular matrix genes, major histocompatibility complex (MHC) genes, as well as
genes in which the products localize to the postsynaptic membrane. We then used public expression datasets from human
fibroblasts to establish transcription modules, sets of genes coexpressed in this cell type. We identified those sets in which
the average gene expression was altered in WBS samples. Dysregulated modules are often interconnected and share
multiple common genes, suggesting that intricate regulatory networks connected by a few central genes are disturbed in
WBS. This modular approach increases the power to identify pathways dysregulated in WBS patients, thus providing a
testable set of additional candidates for genes and their interactions that modulate the WBS phenotypes.
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Introduction
Williams-Beuren Syndrome (WBS; OMIM #194050) is a de
novo neurodevelopmental disorder occurring in approximately 1/
10’000 births. WBS is characterized by mental retardation, with a
unique cognitive and personality profile. Clinical features include
supravalvular aortic stenosis (SVAS), connective tissue anomalies,
distinctive facial features (elfin face), short stature, hypertension,
infantile hypercalcemia, dental, kidney and thyroid abnormalities,
premature ageing of the skin, elevated body fat percentage,
impaired glucose tolerance and silent diabetes. The cognitive
hallmark of the condition is a striking contrast between a relative
strength in auditory memory and language abilities, and a
profound impairment in visuospatial construction. WBS individ-
uals are hypersensitive to sound, with strong emotional responses
to music, either positive or negative, and some individuals display
unusual musical skills. In addition to this hyperacusis, which is
thought to be due to the absence of acoustic reflexes, WBS
individuals may suffer from sensorineural hearing loss as they age.
They are also very sociable, emphatic, loquacious and over-
friendly, with a complete lack of fear towards strangers. Many
present an attention deficit disorder with hyperactivity and anxiety
[1–9].
The WBS is associated with a microdeletion within the 7q11.23
chromosomal band, which encompasses 28 genes [10–13]. It is
flanked by specific low copy repeats that serve as substrate for non-
allelic homologous recombination leading to the deletion [14].
These rearrangements are facilitated by the paracentric inversion
of the region [14,15], as well as the presence of a specific copy
number variant [16]. The most common deletion, occurring in
approximately 95% of cases, involves a 1.5 megabase (Mb)
segment, while a larger 1.84 Mb deletion is observed in about 1 of
20 cases [14,17]. Larger and smaller atypical deletions have been
reported in sporadic cases [18–31].
While the primary cause of WBS is well-understood, we still
know little about the molecular basis of the phenotype. Only very
recently, strains of mice were engineered to carry complementary
half-deletions of the region syntenic to the WBS region, which
replicate several features of WBS, including abnormal social
interaction phenotypes [32]. Yet, so far the dissection of the
phenotype relies mainly on evidence from other mouse models —
e.g. single gene knock-out — and atypical deletions in humans.
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Findings from these studies suggest some correlations between
hemizygosity of certain genes and specific phenotypic features seen
in WBS individuals. For example, the SVAS phenotype was shown
to be unequivocally associated with haploinsufficiency of the
elastin gene [33–35]. Furthermore, mouse models hemizygote for
some of the orthologs of the WBS deletion most telomerically-
mapping genes suggested that these were linked to craniofacial
abnormalities (GTF2I and GTF2IRD1 genes) [36], tooth anomalies
and visuospatial deficit (GTF2I, GTF2IRD1 and GTF2IRD2 genes)
[22,37], as well as deficits in motor coordination (CLIP2) [38].
Likewise, the function of the carbohydrate response element-
binding protein (MLXIPL, a.k.a. ChREBP or WBSCR14) in the
regulation of the expression of enzymes involved in glucose and
lipid metabolism [39-43] suggests that its haploinsufficiency is
associated with the higher relative body fat, silent diabetes and/or
impaired glucose tolerance found in adult WBS individuals [2].
We showed in previous work that the vast majority of the genes
hemizygous due to the 7q11.23 deletion are underexpressed in
lymphoblastoid cell lines and fibroblasts derived from patients [44],
consistent with their possible role in some of the WBS phenotypes.
Some of the genes that map to the flank of the microdeletion might
also influence the WBS phenotype, as it was recently shown that
structural rearrangements affect the relative expression levels of
neighboring normal-copy genes ([44–48], reviewed in [49,50]). To
identify which downstream pathways are perturbed in WBS by these
two classes of human chromosome 7 (HSA7) genes, we generated
genome-wide transcription profiles for primary fibroblasts from eight
individuals with WBS and nine sex- and age-matched controls. We
first focus on differentially expressed genes and then on co-expressed
gene sets to elucidate the genes and pathways that are dysregulated
in WBS and how they may contribute to its clinical phenotypes.
Results
Classical single gene analysis and its limitations
Differentially expressed genes. To assess the effect of the
WBS microdeletion on genome-wide expression, we first profiled
the transcriptome of primary skin fibroblasts of eight WBS patients
and nine sex- and age-matched control individuals using
Affymetrix expression arrays (see Table S1 for the complete list
of samples). These data have been deposited in the NCBI Gene
Expression Omnibus under accession number GSE16715.
Comparison of the WBS individuals with controls using
moderated t-statistics revealed differentially expressed transcripts,
including some of the hemizygous genes, thus partially confirming
previous results [44] (see below). At a false discovery rate (FDR) of
0.05 we identified 1,114 probesets as differentially expressed,
corresponding to 868 genes, which are listed in Table S2. (At a
FDR of 0.01 we obtained 367 probesets, corresponding to 306
genes, see Table S2). All P-values shown were corrected for
multiple hypotheses testing using the Benjamini-Hochberg method
[51]. 56 HSA7 genes are differentially expressed, significantly
more than expected by chance (Fisher’s exact test, P= 0.032).
Eight out of 13 monitored hemizygous genes were differentially
expressed, again, more than expected by chance (Fisher’s exact
test, P= 661025). Furthermore, 3 other out of the 13 hemizygous
genes showed a trend towards downregulation, albeit not statis-
tically significant (Figure 1 and Table S3). These hemizygous
genes, as a gene set, are underexpressed (gene set enrichment
analysis, P= 0.0015). We note that, consistent with previous
results, in particular our own analyses [44], microarrays detect a
lower number of genes than quantitative PCR, due to their
narrower dynamic range.
Enrichment analysis of the differentially expressed
genes. We used these 868 differentially expressed genes (DEG)
to perform gene enrichment analyses. A hypergeometric test on
Gene Ontology (GO) categories uncovered a significant over-
representation of extracellular matrix genes (P= 3.5961025) and
class I major histocompatibility complex (MHC) genes, as well as
genes the products of which localize to the postsynaptic membrane
(all P,0.05, see Table 1 for details). Closer examination of genes
coding for extracellular compartment proteins revealed an
overrepresentation of biological adhesion and binding, as well as
structural molecules, while localization and transporter activity
were underrepresented functions (Figure S1).
Instead of considering the expression levels of single genes, a
more robust approach is to work with gene sets. One such method
is gene set enrichment analysis [52–54], in which the aggregated
expression level of a pre-defined group of genes is tested for
difference between two biological states. Yet, the scope of
enrichment analyses for genes in pre-defined functional categories
is limited for several reasons: first, even though more than 80% of
human genes have now been annotated in GO, the experimental
evidence for these annotations differs widely (with less than 30% of
the genes having at least one experimental annotation [55]).
Second, the categorization and annotation is obviously biased by
human interpretation and reflects research foci. Finally, co-
regulation of genes belonging to a functional category may not
be induced transcriptionally or if so, only partially. In order to
overcome these limitations, we sought to complement our
enrichment analysis with functional gene categories directly
derived, in an unbiased manner, from gene expression data. We
refer to such units of transcripts that exhibit coherent expression
across a subset of the experimental samples as transcription modules
(see below). This approach is based on the hypothesis that
transcripts belonging to the same module are likely to play a role in
the same pathway (or any biological process) and that their
average expression levels can be used as a proxy for the induction
or suppression of this pathway. An additional benefit of this
approach is that it can also highlight novel functional links for
genes that have no or fragmented annotation so far.
Author Summary
A fundamental question in current biomedical research is
to establish a link between genomic variation and
phenotypic differences, which encompasses both the
seemingly neutral diversity, as well as the pathological
variation that causes or predisposes to disease. Once the
primary genetic cause(s) of a disease or phenotype has
been identified, we need to understand the biochemical
consequences of such variants that eventually lead to
increased disease risk. Such phenotypic effects of genetic
differences are supposedly brought about by changes in
expression levels, either of the genes affected by the
genetic change or indirectly through position effects. Thus,
transcriptome analyses seem appropriate proxies to study
the consequences of structural variation, such as the
7q11.23 deletion present in individuals with Williams-
Beuren syndrome (WBS). Here, we present an approach
that takes experimental data into account instead of
relying solely on functional annotation, following the
rationale that coherently regulated genes are likely to play
a role in the same biological process. While our algorithm
can be applied to expression data from any source, our
study provides a resource for the identification of
additional candidate genes and pathways to explain the
WBS phenotype, as well as a basis for uncovering novel
functional interactions between sets of genes.
Transcription Modules
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Using modular analysis to explore the pathophysiology
of WBS
Identifying transcription modules from fibroblast
expression data. In our first modular study (to which we
refer as M1), we collected skin fibroblast microarray datasets,
unrelated to our study, and used them to identify sets of co-
expressed genes in fibroblasts (see Table S4 for a complete list of
included datasets, their descriptions and accession numbers).
Towards this end we used the Iterative Signature Algorithm (ISA)
[56], a powerful tool for the rapid identification of transcription
Figure 1. Differential expression of the WBS hemizygous and flanking genes. Genes are ordered according to their chromosomal position.
Shaded areas represent the LCRs flanking the deletion. Gene names are indicated at the bottom and corresponding differential expression P-values at
the top. For genes with multiple probesets the most significant P-value is considered. Red bars indicate significance (P,0.05). Genes without a P-
value were not detected on the array and thus not tested.
doi:10.1371/journal.pcbi.1001054.g001
Table 1. GO terms enriched in the set of differentially expressed genes.
GO ID
BH-adjusted
P-value Direction
Odds
Ratio
Expected
Count Count
Category
Size Term
GO:0005576 2.64E-06 ind/sup 2.12 48.61 89 592 extracellular region
GO:0031226 2.29E-05 ind/sup 2.26 32.19 63 392 intrinsic to plasma membrane
GO:0031012 3.59E-05 ind/sup 3.25 11.58 31 141 extracellular matrix
GO:0005887 3.70E-05 ind/sup 2.2 31.78 61 387 integral to plasma membrane
GO:0005578 6.27E-05 ind/sup 3.21 10.92 29 133 proteinaceous extracellular matrix
GO:0044421 1.01E-04 ind/sup 2.32 23.73 48 289 extracellular region part
GO:0044459 3.60E-04 ind/sup 1.75 57.32 90 698 plasma membrane part
GO:0005886 1.59E-03 ind/sup 1.52 101.58 139 1237 plasma membrane
GO:0042612 2.17E-03 ind 11.28 1.15 7 14 MHC class I protein complex
GO:0005581 8.08E-03 ind/sup 6.45 1.81 8 22 collagen
GO:0042611 8.08E-03 ind 7.9 1.4 7 17 MHC protein complex
GO:0044420 1.27E-02 ind/sup 3.51 4.52 13 55 extracellular matrix part
GO:0032393 1.82E-02 ind 22.11 0.75 6 9 MHC class I receptor activity
GO:0005201 1.82E-02 ind/sup 5.55 2.76 11 33 extracellular matrix structural
constituent
GO:0045211 1.87E-02 ind/sup 4.62 2.55 9 31 postsynaptic membrane
GO:0002474 2.00E-02 ind 10.86 1.36 8 16 antigen processing and presentation
of peptide antigen via MHC class I
GO:0048002 2.00E-02 ind 10.86 1.36 8 16 antigen processing and presentation
of peptide antigen
GO:0004888 3.74E-02 ind/sup 2.16 17.64 34 211 transmembrane receptor activity
doi:10.1371/journal.pcbi.1001054.t001
Transcription Modules
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modules. Briefly, the ISA identifies, from a large set of expression
data, subsets of samples for which certain sets of genes are
coherently over- or underexpressed. We refer to these subsets as
modules, and each sample and gene receives scores indicating
their membership (if non-zero) and contribution to each module.
The algorithm found 1’094 modules of genes that are co-expressed
in specific subsets of samples. An interactive database of these
modules is accessible online at http://www.unil.ch/cbg/ISA/
Fibroblasts. They reflect the transcriptional responses to the given
perturbations, either natural or specific to the experiments that
were conducted on the fibroblast samples. 916 out of the 1’094
modules are functionally enriched, indicating that they correspond
to co-regulated genes involved in particular pathways that are
transcriptionally regulated.
To test whether some of the identified modules are differentially
expressed in WBS patients compared to controls we calculated the
weighted average expression of the genes of each module, using
the ISA gene scores as weights. This was done separately for each
WBS and control sample, after which the two groups were
compared using a t-test. We identified 72 modules with
significantly altered expression, by applying a 0.05 cutoff on the
Benjamini-Hochberg corrected P-values (Table S5). A permuta-
tion test was used to validate these results (see Materials and
Methods for details). The functional enrichments of these modules
are consistent with those in the single-gene differential expression
analysis. Indeed, many modules are enriched in genes annotated
for the extracellular compartment and immune response, but also
in DNA binding and transcription (a summary is given in Table 2,
see Tables S5 and S6 and Figure S1 for details).
Including theWBS data in the discovery of modules. Next,
we searched specifically for coherent perturbations in gene
expression driven by the WBS deletion. To this end, we
performed a second modular study (to which we refer as M2),
which included both the WBS samples and the data sets used
previously. The ISA algorithm found 1,035 modules, of which 868
are functionally enriched and 368 contain at least one sample from
our study. An interactive database of these modules is accessible
online at http://www.unil.ch/cbg/ISA/Fibroblasts. Out of the 368
modules including one of our samples, 290 contain at least ten genes
and were tested for differential expression. Specifically, a t-test, as
above, on the weighted mean expression of these module genes
identified 23 modules that were significantly dysregulated in the
WBS case samples (listed in Table S7). An example of such a
module is given in Figure 2. The remaining modules with
unchanged expression thus represent functions that are unaffected
in WBS. To check the significance of this result we randomly
permuted the WBS case/control labels 1,000 times. We observed
that none of these permutations yielded even a single dysregulated
module.
Hierarchy of the modules. Several smaller modules are
included completely in other larger ones, forming a hierarchical
structure. We organized the 72 and 23 dysregulated modules
identified in M1 and M2, respectively, into a directed graph based
on their subset relationships, i.e. two modules are connected by a
directed edge, if all the genes in the first module are included in the
second (see Figure 3 and http://www.unil.ch/cbg/ISA/
Fibroblasts). This graph has nine non-trivial components, with 3
to 19 modules each. Some of these modules can be readily linked
to the WBS phenotype based on their functional enrichment, e.g.
modules M1-349 and M1-257 (75 and 51 genes, respectively),
which display multiple functional enrichments, notably in
vasculature development and regulation, response to wounding,
as well as chemotaxis and immune response (see website for the full
lists and details). Interestingly, both modules contain the NR4A3
gene (M1-349 also contains SPRY2), which are genes involved in
the development of the inner ear. About one quarter of the gene
products of these two modules localize to the extracellular region
(19/75 and 14/51 genes, respectively).
WBS hemizygous genes in the dysregulated modules. We
found that the dysregulated M1 modules include only two
hemizygous genes (i.e. WBSCR22B and LAT2 (a.k.a. WBSCR5)),
while five other hemizygous genes, namely EIF4H, BAZ1B, BCL7B,
Table 2. Summary of GO terms and KEGG pathways enriched in the dysregulated transcription modules, M1 modular analysis.
GO ID BH-adjusted p-value Count Category size Best module (size) GO term
GO:0005576 2.92E-07 44 445 958 (294) extracellular region
GO:0031012 5.20E-05 18 114 957 (323) extracellular matrix
GO:0045449 1.23E-04 90 1084 1012 (542) regulation of transcription
GO:0010468 1.23E-04 97 1213 1012 (542) regulation of gene expression
GO:0005125 1.25E-04 7 34 349 (75) cytokine activity
GO:0003677 1.25E-04 85 971 1012 (542) DNA binding
GO:0032501 1.29E-04 30 1167 349 (75) multicellular organismal process
GO:0009887 1.29E-04 14 224 349 (75) organ morphogenesis
GO:0002376 1.58E-04 16 327 349 (75) immune system process
GO:0042127 2.17E-04 15 291 349 (75) regulation of cell proliferation
GO:0005057 3.02E-04 8 88 753 (120) receptor signaling protein activity
GO:0009611 3.88E-04 11 156 349 (75) response to wounding
GO:0042612 4.51E-04 6 13 1037 (341) MHC class I protein complex
GO:0008283 5.55E-04 17 437 349 (75) cell proliferation
GO:0006954 6.16E-04 10 98 747 (151) inflammatory response
GO:0009605 6.69E-04 13 252 349 (75) response to external stimulus
GO:0007165 8.14E-04 30 1342 349 (75) signal transduction
doi:10.1371/journal.pcbi.1001054.t002
Transcription Modules
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ELN and TBL2, were integrated into a total of 10 dysregulated M2
modules. All these genes, except LAT2, show differential expression
between WBS case and control samples (see Figure 1 and Table
S3). Furthermore, among the 844 genes that compose the 23
dysregulated M2 modules, HSA7 genes are overrepresented,
appearing 1.37 times more frequently than expected by chance
(P= 0.048, Fisher’s exact test). Modules containing hemizygous
genes are enriched in membrane and extracellular proteins, as well
as genes involved in immune response and organ development (a
summary of the functional enrichment of M2 modules is given in
Table 3, see Tables S7 and S8 and Figure S1 for details).
Genes that appear frequently in dysregulated
modules. The severity of a phenotype correlates with the
connectivity and thus centrality of the associated gene within the
functional network [57,58]. Based on this observation, we
reasoned that the most frequent genes among our expression
modules — and hence with the most connections in our dataset
— are more likely to play a central role in the pathophysiology of
WBS. We therefore considered the genes that were found by both
the M1 and M2 modular studies and counted their occurrence in
dysregulated modules. The M1 dysregulated modules contain
1984 different genes, while 844 different genes appear in M2
modules. 392 genes are present both in M1 and M2 modules, the
most frequent ones being: UCP2, EGFL6, C10orf116, HSPB2,
PSMB9, SPON1, C4orf31, GABRE, ABHD14A and AGBL5 (see
Table S9 for a more complete list). The frequency of a gene in
both module sets does not correlate with its differential expression
for the first set of modules (M1, Pearson correlation 0.07), and it
correlates positively for the second set (M2, Pearson correlation
0.33). To verify the functional connectivity of these most frequent
genes we interrogated the STRING database that compiles
known and predicted protein-protein interactions (http://string-
db.org) [59]. We found that not only do these genes interact more
with each other than expected by chance, as measured by the
number of edges connecting them, but they also have more
connections to the whole than a random subset of gene products.
They also tend to have higher centrality scores and thus are closer
to the center of the protein interaction network (Figure 4A–D).
This correlation between frequency in the modules and degree of
connectivity or centrality holds true for all genes in all modules
regardless of their dysregulation in WBS (see Figure S2). To
understand better the organization of the network of frequent
genes, we fitted a hierarchical statistical model [60] to it. In this
context, hierarchy means that the genes are organized into
groups, within which they are connected with a higher pro-
bability. These groups are organized into even denser subgroups,
and so on. The statistical model infers such a structure from the
data. According to our results, however, the network of frequent
genes lacks a hierarchical structure (Figure 4E). GO and KEGG
enrichment calculation for the 392 common transcripts shows
significant enrichment for several categories consistent with those
identified in the single-gene differential expression analysis and
the modules (Table S10).
Interestingly, the function of some of these frequently occurring
genes may be relevant to the pathophysiology of some WBS
features, such as metabolic phenotypes (UCP2 [61]), dental
anomalies (SPON1 [62]), neurological features, cognition or brain
development (HSPB2, [63], ABHD14A [64] and GABRE [65]).
Also, the overrepresentation of genes related to the immune
response in the list of most frequent genes hints at a putative
immunological component of the syndrome, which has hitherto
not been suspected from the clinical phenotype alone.
Comparison with lymphoblastoid cell lines from WBS and
control individuals
Gene expression in fibroblasts can only provide a partial picture
of the gene dysregulation that gives rise to the WBS clinical
Figure 2. Example of a WBS dysregulated module (#770 from
the M2 module set). This module contains 149 genes (one per line)
and 9 samples (columns). Seven samples are from WBS patients
(denoted with ‘‘W’’), C-5290 is a control sample from our dataset, while
HPGS-9 belongs to a publicly available dataset. Gene scores are plotted
on the left and sample scores at the top. The 59 genes with positive
gene scores (bottom lines) are downregulated (green) in the seven WBS
samples and upregulated (red) in the other two. The remaining 90
genes show the opposite pattern: they are upregulated in the WBS
samples and downregulated in the remaining two samples. Hemizy-
gous gene names are emphasized in red and the names of genes
mapping to HSA7 in boldface. Red asterisks indicate genes belonging
to the GO category ‘‘extracellular region’’ while black asterisks denote
genes from the ‘‘intrinsic to membrane’’ category.
doi:10.1371/journal.pcbi.1001054.g002
Transcription Modules
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phenotypes. Thus, data from other cell types or tissues may
provide additional clues as to dysregulated pathways, as well as
confirm some of our findings in fibroblasts. Indeed, comparison
with the recently published transcriptome of lymphoblastoid, i.e.
EBV-transformed, cell lines from WBS patients [66] revealed a
few commonly dysregulated genes. The expression of 11 common
genes was altered with the same sign in both cell types, while for 29
others we observe opposite expression (Table S11). Eight of the
11 genes with consistently altered expression were part of 28
dysregulated M1 or M2 modules (Table S11).
Figure 3. Hierarchical diagram of the transcription modules dysregulated in WBS identified in the M1 (left) and M2 (right) modular
studies. Directed edges indicate direct subset relationships, and they always point upwards. The number of genes in a module is shown at the top
left corner of the module box. Modules annotated with a red star on their top right corner contain at least one hemizygous (or flanking) gene; the
ones with green stars on their bottom right corner were replicated in lymphoblastoid cell lines; blue stars on the bottom left corner indicate modules
that show significant enrichment for extracellular region genes. An interactive version of this figure is available in the online supporting material at
http://www.unil.ch/cbg/ISA/Fibroblasts, which allows to further query the gene content and functional enrichment of the modules.
doi:10.1371/journal.pcbi.1001054.g003
Table 3. Summary of GO terms and KEGG pathways enriched in the dysregulated transcription modules, M2 modular analysis.
ID BH-adjusted p-value Count Category size Best module (size) Term/name
GO:0005576 1.78E-12 73 700 991 (373) extracellular region
GO:0006955 1.62E-06 17 295 503 (73) immune response
GO:0031224 2.09E-05 89 2051 806 (239) intrinsic to membrane
GO:0009605 2.78E-05 17 370 503 (73) response to external stimulus
GO:0005102 1.02E-04 16 408 503 (73) receptor binding
GO:0007165 3.95E-04 35 1800 503 (73) signal transduction
GO:0042824 4.27E-04 4 6 702 (163) MHC class I peptide loading complex
GO:0007154 7.32E-04 36 1947 503 (73) cell communication
GO:0008083 8.75E-04 8 94 503 (73) growth factor activity
GO:0042330 2.88E-03 7 69 503 (73) taxis
GO:0009887 2.88E-03 13 312 503 (73) organ morphogenesis
GO:0007626 2.98E-03 8 101 503 (73) locomotory behavior
GO:0005578 3.21E-03 18 156 991 (373) proteinaceous extracellular matrix
GO:0001525 3.47E-03 8 104 503 (73) Angiogenesis
KEGG: 4060 7.51E-04 10 122 503 (73) Cytokine-cytokine interaction
doi:10.1371/journal.pcbi.1001054.t003
Transcription Modules
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Out of the 72 M1 modules the average gene expression of which
is altered in WBS fibroblasts, seven are also changed in the
lymphoblastoid cell lines; four modules are altered in the same
direction, three modules are opposite in the two studies. Moreover,
19 of the 23 dysregulated M2 modules are also perturbed in the
lymphoblastoid samples, 18 in the same direction (Table S11),
suggesting that the pathways identified in the fibroblasts are
disrupted in multiple tissues. Furthermore, we can surmise that
modules consistently regulated in both cell types may represent
central pathways influenced by the WBS deletion, while the
remaining modules may reflect cell-type specific alterations, which
in turn might be important for tissue-specific phenotypes.
Discussion
We have profiled the transcriptomes of skin fibroblasts from eight
WBS patients and nine sex- and age-matched control individuals,
and identified a number of transcription modules dysregulated in
WBS patient cells. One caveat of this study lies in the use of isolated
cells in vitro that may not reflect all the different tissue-dependent
transcriptional changes in vivo that give rise to the complex WBS
phenotypes, such as cognitive features or connective tissue
anomalies. Moreover, the samples we consider only allow us to
observe the downstream global effects of the primary cause, as
opposed to the immediate effect on early development. However,
these cell types are the most readily available samples, and the
replication of a subset of the fibroblast dysregulations in
lymphoblastoids supports the hypothesis that at least some of these
changes appear in multiple cell types as a direct result of the 7q11.23
deletion and thus provide clues about pathways that may generally
be perturbed in WBS. Our results reveal a transcriptional network
which may contribute to the pathophysiology of WBS. We propose
that many of the WBS phenotypes arise due to the dysregulation of
a few key gene products, which influence (possibly in concert)
‘‘regulatory subnetworks’’, leading to specific traits. Also, distur-
bances in a process due to one group of genes may trigger
compensatory mechanisms in another set, either directly in the cell,
or indirectly through intercellular or more systemic effects.
Figure 4. The network of the most frequent genes in the modules, as a subset of the STRING protein interaction database. Only
genes that appear at least ten times in the dysregulated modules are considered. (A) Most frequent module genes that have at least one connection
in the STRING database. Edges with evidence score higher than 0.3 are shown; their colors indicate different kinds of interaction evidence (key
bottom right). (B) Most frequent module genes form a network that is denser than a random subnetwork of the same size in STRING. We generated
10,000 random subnetworks and calculated the sum of the evidence for all edges. Only five out of all random subnetworks show a higher total
evidence value than the most frequent module genes indicated by a red asterisk (sum of total evidence= 69,033). (C) Distribution of the number of
connections (node degree) per protein in the complete STRING network (black, filled circles), and the subnetwork of most frequent module genes
(red, open squares). The subnetwork has significantly less low-degree nodes and more high-degree nodes (Wilcoxon-test P= 1.61261025). (D)
Distribution of PageRank centrality scores in the complete STRING network and the subnetwork of most frequent module genes. The subnetwork has
fewer non-central nodes and more central nodes (Wilcoxon-test P= 2.62861025). (E) We fitted hierarchical models [60] to the subnetwork of the most
frequent module genes, and also to 1,000 randomized networks. The network of frequent module genes (red asterisk) shows no hierarchical structure
compared to the randomized networks.
doi:10.1371/journal.pcbi.1001054.g004
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Both our single-gene and modular analyses provide a resource
to enable a deeper exploration of the pathophysiology of WBS,
which may lead to the discovery of potential novel functional
interactions between their products. Our study further exemplifies
how integration of transcription data unrelated to the studied
condition can be used to complement annotation-dependent
analyses. Indeed, the modular approach reduces the complexity of
the expression data, allowing a more targeted assignment of
functional categories to specific sets of co-regulated genes.
Consistently, Turcan et al. recently used a similar methodology
to identify groups of genes coherently regulated during cochlear
development, which allowed them to pinpoint candidate genes for
further study [67]. It is important to underline that further
investigations and more data are needed to distinguish between
biologically relevant associations of differentially regulated mod-
ules and spurious co-expression signals. Nevertheless, we think that
the information generated by our study (and made available at
http://www.unil.ch/cbg/ISA/Fibroblasts) provides a testable set
of candidate pathways dysregulated in WBS and possibly involved
in mediating the wide range of associated phenotypes.
Materials and Methods
Ethics statement
We have obtained the approval of the ethics committees of the
University of Lausanne (reference number Protocol 123/06) and
of the ‘‘Hospices Civils de Lyon’’ for this project. All patients
provided written informed consent for the collection of samples
and subsequent analysis.
Sample population
Skin fibroblasts of 8 classical WBS and 9 control Caucasian
female individuals aged between 3 and 8 years (see Table S1 for
details) and similar numbers of passages were obtained from the
cell culture collections of the Centre de Biotechnologie Cellulaire,
CBC Biotec, CRB-Hospices Civils de Lyon, Lyon, France. The
respective presence and absence, as well as the extent of the
deletion were ascertained by SybrGreen real-time quantitative
PCR as previously described [26].
Cell culture, RNA extraction and microarrays
Human skin fibroblasts were grown in HAM F-10, supplement-
ed with 10% fetal bovine serum and 1% antibiotics (all Invitrogen).
Total RNA was prepared using TriZOL Reagent (Invitrogen) and
RNeasy Mini Columns (Qiagen) according to the manufacturers’
instructions. The quality of all RNAs was assessed using an Agilent
2100 Bioanalyzer (Agilent Technologies) and used as a template for
complementary DNA (cDNA) synthesis and biotinylated antisense
cRNA preparation. The synthesis of cDNA and cRNA, labeling,
hybridization and scanning of the samples were performed as
described by Affymetrix (www.affymetrix.com). The cRNA
samples were hybridized to GeneChip Human Genome U133
Plus 2.0 arrays (Affymetrix). The chips were washed, stained and
scanned, according to the manufacturer’s protocol.
Accession number
The data of the 17 expression arrays produced for this report
have been deposited in NCBIs Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/) and are accessible through
GEO Series accession number GSE16715.
Single gene expression data analysis
Expression data analyses were performed using GNU R (version
2.9.2) [68] and the Bioconductor package (version 2.4) [69]. All R
package versions are listed in Table S12. Low-level analysis and
normalization were done using GCRMA. For differential
expression analysis we filtered the probesets and kept only those
present in at least six samples, according to the Affymetrix
Present/Absent calls calculated with the affy R package. To
reduce noise, we also removed probesets that do not map to an
Entrez gene. 18,429 probesets, mapping to 10,570 genes were
tested for differential expression, using the moderated t-statistics,
as implemented in the limma R package. In addition to the
significant p-value, we required a minimum of 50% change for
declaring a gene differentially expressed. 1,114 probesets,
corresponding to 868 genes were found differentially expressed
at the 5% FDR level, 367 probesets, mapping to 306 genes at the
1% FDR level. The FDR was controlled using the Benjamini-
Hochberg correction [51]. Gene set enrichment analysis of the
WBS hemizygous genes was performed by comparing the mean t-
statistics of these genes, for the WBS patients and the control
individuals; the reference distribution for this was established by
permuting the phenotype labels 10,000 times [70]. Gene Ontology
and KEGG Pathway enrichment was calculated via a hypergeo-
metric test, using the eisa and GOstats Bioconductor packages.
The enrichment P-values were corrected using the Benjamini-
Hochberg method for the number of categories tested.
Modular analysis
A transcription module comprises a subset of genes that are co-
expressed in a subset of conditions [56]. The Iterative Signature
Algorithm (ISA) [71] is an unsupervised method to identify such
modules. It starts from many random initial sets of genes (seeds) that
typically converge to a set of potentially overlapping transcription
modules. The ISA assigns a signed score to every gene of the module
and every sample of the module (zero scores imply that the gene or
sample is not included in the module). The further the gene/sample
score is from zero, the stronger the association between the gene/
sample and the rest of the module. Co-expressed genes of a module
have the same sign, whereas opposite signs signal opposite
expression. The scores of the samples are exactly the same as the
weighted averages of the expression of the module genes, the
weights being the scores of the genes. Sample scores can be
extended to the samples that are not included in the module, by
calculating the same weighted average of the module genes for
them. These samples have (in absolute value) lower scores than the
module samples, by definition. The extended sample scores can be
used to test whether the genes of a module are differentially
regulated in some samples. The aim is to identify dysregulated
transcription modules containing genes that are differentially
expressed in the cases compared to the control samples.
Discovering transcription modules in data sets unrelated
to WBS (M1)
In the first ISA run, we used skin fibroblast samples from seven
experiments from public repositories, as well as collaborators of the
AnEUploidy consortium (the latter can be obtained by contacting
the consortium at http://www.aneuploidy.eu/) (Table S4). For
each dataset we downloaded the raw data and normalized them
separately with the GCRMA method. The non-common probesets
were omitted and the normalized expression data were merged; the
data set included 22,277 probesets and 96 samples. To reduce noise
we removed probesets that were called ‘‘Present’’ in less than ten
samples, using the standard Affymetrix Present/Absent calls. We
also removed probesets that were not associated with any Entrez
gene. In order to avoid a bias towards genes with multiple probesets
we only kept the single probeset with the highest variance for those
genes. The final dataset included 9,329 probesets.
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We applied the ComBat batch correction algorithm [72] to
minimize non-biological variation; we used the ‘‘disease status’’ of
the samples as an additional covariate for the correction (column
‘‘disease status’’ in Table S4). The additional covariate ensures
that we do not remove the signal associated with the different
syndromes in the data sets, only the systematic experimental
variation. We ran ISA as implemented in the eisa R package [73],
with gene thresholds 2, 2.2, …, 4 and sample thresholds 1, 1.2, …,
2. The ISA identified 1,094 transcription modules.
For the identification of the dysregulated modules, we used the
GCRMA normalized WBS data set. Probesets that were called
‘‘Present’’ in less than six samples were omitted from the analysis.
We only considered the 7,447 probesets that were included both in
this filtered WBS data set and the modular study.
732 modules that contained at least ten genes were tested for
dysregulation. For the dysregulation test we standardized the WBS
expression data for every gene separately. Standardization is an
important step, since the test for dysregulation involves the average
expression of the module genes. Specifically, to test a module, we
calculated the weighted average expression of its genes, separately
for each WBS sample. The weights were defined by the gene
scores of the module. Then a t-test with unequal variance was
performed for the WBS cases against controls. The t-test P-values
were corrected with the Benjamini-Hochberg method. At the 5%
FDR level 72 dysregulated modules were found.
To check the significance of finding 72 dysregulated modules,
we permuted the WBS case/control labels 1,000 times and tested
for dysregulation as before. These permutations serve as a null-
model to estimate how many dysregulated modules could have
resulted by chance. Only 14 permutations yielded at least one
dysregulated module. Within these 14 cases, the mean number of
dysregulated modules was 12.1, the median 1.5. The highest
number of dysregulated modules found for a permutation was 58.
We note that the three permutations that yielded multiple (false
positive) WBS dysregulated modules had almost correct WBS
case/control labels: only one pair was swapped.
Hypergeometric tests were used to calculate the functional
enrichment of the 72 dysregulated modules, with Benjamini-
Hochberg correction for the number of categories and the number
of modules tested. The significance threshold was chosen as 0.05.
Including the WBS data in the discovery of modules
The second modular study (M2) was performed almost
identically, but this time the WBS samples were also included in
the data set. The ISA was run on 9,460 probesets and 113
samples, using gene thresholds 2, 2.2, …, 4 and sample thresholds
1, 1.2, …, 2. The ISA found 1,035 modules, of which 290 contain
at least ten genes and one sample from our study. These were
tested for dysregulation using t-tests for the sample scores of the
WBS cases vs. controls, identifying 23 modules that are
differentially expressed. As an additional validation, we permu-
tated the labels of the WBS samples 1,000 times; no permutation
showed any dysregulated modules. Enrichment calculation for the
dysregulated modules was done the same way as for the M1
modules, using Benjamini-Hochberg multiple testing correction
for the number of categories and the number of modules tested,
and a significance threshold of 0.05.
The network of genes that frequently appear in
dysregulated modules
We used version 8.3 of the STRING database to interrogate the
genes that frequently appear in the dysregulated modules. All
network measures were calculated using the igraph R package
[74]. We fitted hierarchical models [60] to the subnetwork of
frequent module genes, and also to 1,000 randomized networks.
For fitting the hierarchical models, we only considered the largest
connected component of the network, consisting of 90 proteins
and 203 connections among them. The randomized networks had
the same degree sequence as the original network, and they were
produced using Monte-Carlo methods [75].
Enrichment calculations for the extracellular region
genes
The enrichment calculations for the extracellular region genes
(Figure S1) were done using hypergeometric tests and the eisa and
GOstats R packages. Only the second level terms in the ‘‘Biological
process’’ and ‘‘Molecular function’’ ontologies were tested.
Comparison of WBS lymphoblastoid cell lines and
primary skin fibroblasts, transformed and non-
transformed cells, respectively
To identify genes commonly dysregulated in cells from WBS
patients identified in this study and in [66], which uses two-color
arrays (GEO accession number GSE18188), we tested the
lymphoblastoid samples for differentially expressed genes. We used
the moderated t-statistics and a fold-change threshold of 1.5 and
applied the Benjamini-Hochberg multiple testing correction
method to identify 574 differentially expressed genes. Forty of these
are common with the 868 differentially expressed genes we found in
the fibroblast samples. To test the dysregulation of the fibroblast
dysregulated modules in the lymphoblastoid samples, we calculated
the weighted mean log fold change of the module genes for each
lymphoblastoid array, where the gene scores of the modules were
used as weights. Then we used a t-test to check whether the mean
log fold change is significantly above or below zero, followed by the
Benjamini-Hochberg multiple testing correction method.
Online supporting material
The modules and related details are available at http://www.
unil.ch/cbg/ISA/Fibroblasts. These web pages contain the
summary of all M1 and M2 transcription modules and their
GO/KEGG enrichment statistics. An interactive version of
Figure 3 is also included; this allows the exploration and
annotation of the dysregulated modules, using various criteria. It
is also possible to query the modules that contain a specific gene,
or a list of genes. See the help page of the supplementary material
for details. Additionally, the modules can be visualized interac-
tively with the online version of ExpressionView [76].
Annotation data and databases
The expression array annotation data were taken from the
hgu133a2.db (version 2.2.11) and hgu133plus2.db (version 2.2.11)
Bioconductor packages. The GO.db package (version 2.2.11) was
used for the Gene Ontology and the KEGG.db package (version
2.2.11) for the KEGG pathway data.
Software packages are listed in Table S12.
Supporting Information
Figure S1 Over- and under-representation of GO biological
process and molecular function terms among ‘‘extracellular
compartment’’ annotated genes of the DEG list and each set of
dysregulated modules. Dark coloured bars denote significant
enrichment/depletion. P-values (p) and odds ratios (o) are
indicated. Terms marked in boldface display consistent direction
of change in all sets and with significance in at least one set.
Found at: doi:10.1371/journal.pcbi.1001054.s001 (2.61 MB EPS)
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Figure S2 (A) Relationship between the number of times genes
appear in transcription modules (M1, M2, or their union) and
their number of connections in the STRING database. First row:
genes were binned according to their frequency in modules, and
the mean STRING degree of each bin is plotted. The line is the fit
from the linear regression of STRING degree on frequency, the
slope is always significant with a p-value less than 1029. Second
row: the mean (black) and median (blue) degree is plotted for the
genes that appear at least a given number of times in the modules.
In other words, the first point is the mean/median degree of all
genes, the second data point is the mean/median degree of all
genes that appear at least once in a module, etc. There is a clear
correlation between the frequency in the modules and STRING
degree. (B) Relationship between the number of times genes
appear in modules and their PageRank centrality in the STRING
network. The plots are essentially the same as in (A), but the
PageRank centrality is plotted instead of degree. There is a clear
correlation between the frequency in the modules and the
centrality of the genes in the STRING network.
Found at: doi:10.1371/journal.pcbi.1001054.s002 (1.14 MB EPS)
Table S1 Cell line information.
Found at: doi:10.1371/journal.pcbi.1001054.s003 (0.02 MB XLS)
Table S2 Differentially expressed genes in WBS samples
compared to controls.
Found at: doi:10.1371/journal.pcbi.1001054.s004 (0.23 MB XLS)
Table S3 Differential expression of the WBS hemizygous and
flanking genes.
Found at: doi:10.1371/journal.pcbi.1001054.s005 (0.02 MB XLS)
Table S4 Datasets used for modular analysis.
Found at: doi:10.1371/journal.pcbi.1001054.s006 (0.02 MB XLS)
Table S5 Dysregulated modules, M1.
Found at: doi:10.1371/journal.pcbi.1001054.s007 (0.04 MB XLS)
Table S6 GO/KEGG term enrichment in dysregulated M1
modules.
Found at: doi:10.1371/journal.pcbi.1001054.s008 (0.07 MB XLS)
Table S7 Dysregulated modules, M2.
Found at: doi:10.1371/journal.pcbi.1001054.s009 (0.03 MB XLS)
Table S8 GO/KEGG term enrichment in dysregulated M2
modules.
Found at: doi:10.1371/journal.pcbi.1001054.s010 (0.05 MB XLS)
Table S9 Most frequently occurring genes among dysregulated
M1 and M2 modules.
Found at: doi:10.1371/journal.pcbi.1001054.s011 (0.08 MB XLS)
Table S10 GO/KEGG term enrichment among genes common
to both sets of dysregulated modules.
Found at: doi:10.1371/journal.pcbi.1001054.s012 (0.04 MB XLS)
Table S11 Dysregulated single genes and modules common to
fibroblasts and lymphoblastoid cell lines.
Found at: doi:10.1371/journal.pcbi.1001054.s013 (0.03 MB XLS)
Table S12 Software packages used for the analysis.
Found at: doi:10.1371/journal.pcbi.1001054.s014 (0.03 MB XLS)
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